REQUEST A DEMO
Total
USD $0.00
Search more companies

Seutic Pharma Private Limited (India)

Main Activities: All Other Chemical Product and Preparation Manufacturing
Full name: Seutic Pharma Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Seutic Pharma Private Limited is an unlisted company, incorporated on 23/07/2014. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24297TG2014PTC095025 and registration number is 095025. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
2Nd Floor , D-73/P , D-74/P ,Quthbullapur , Apiidc Phase-1 , Jeedimetla
Hyderabad; Telangana; Postal Code: 500055

Contact Details: Purchase the Seutic Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Seutic Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Seutic Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Seutic Pharma Private Limited report to view the information.
Incorporation Date:
July 23, 2014
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Seutic Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
83.76%
Total operating revenue
83.76%
Operating profit (EBIT)
86.55%
EBITDA
59.56%
Net Profit (Loss) for the Period
133.89%
Total assets
57.63%
Total equity
24.73%
Operating Profit Margin (ROS)
0.05%
Net Profit Margin
0.42%
Return on Equity (ROE)
9.25%
Debt to Equity Ratio
129.17%
Quick Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?